Summary: Proportions of collagen type I and type III were investigated in different tissues (kidney, liver, heart muscle, esophagus, lung and skin) in a single case of malignant systemic scleroderma. The proportion of collagen type HI was higher than in healthy controls. Similarly, an increase in the proportion of collagen type III was shown in tissues affected by other inflammatory diseases. Further the authors suggest that the increase in total kidney collagen, especially type III, has important consequences for kidney function; in the described case it had the critical influence on the fatal course of the disease, and the patient died from uremia.
Introduction
Current knowledge of systemic scleroderma extends mainly to the descriptive phase, and our understanding of the disease remains superficial. The skin and subcutaneous elements are not exclusively affected, but the process may be widespread and involve virtually all the tissues of the body. The prognosis of life in the patient with systemic scleroderma depends on the presence and degree of visceral involvement. The most critical organ involvement^ which can be fatal in ä matter of weeks or several months, are renal or cardiopulmpnary. On the other hand esophageal hypomobility is the most common visceral manifestation of scleroderma, and it often appears early. Histologie examinations of systemic scleroderma lesions show alteration of collagen fibers (1) . On the other hand the results of different authors (2, 3) suggest increased collagen biosynthesis in a number of patients with systemic scleroderma.
Recent advances in collagen chemistry have made possible the detailed characterization of the insoluble ifraction. These studies have led to the discovery of collagen heterogeneity. The more abundant type I collagen of molecular composition ( ( )) 2 2 is present, together with another genetically distinct collagen type III of molecular composition (a 1 (III)) 3 in interstitial tissues. Other genetically distinct collagens are: collagens type IV of composition (ai(IV))3, and the newly discovered type V from blood vessels, composed of chains oA and aB (4) . The occurrence of collagen polymorphism has been identified in different tissues such as skin, aorta, liver, lung, kidney, synovial membrane, peripheral nerve. The content of collagen type II in the loose connective tissue changes in certain physiological and pathological states.
In this report we present data suggesting an increase in .the quantity of collagen type III in different tissues 0340-076X/79/0017-0495S02.00involved with systemic scleroderma, as well as other sources of inflammatory diseases.
Material and Methods
Samples of tissues One case of malignant systemic scleroderma was studied. This was a 42 year-old female, in which only six months elapsed between the onset of symptoms and death. In spite of high doses of corticosteroids, the situation of the patient rapidly became worse; urea nitrogen in the blood increased to 119 mg/dl, severe chest pains appeared, extrasystolae were observed in ECG and finally anuria occured before exitus. Ischemic necroses of renal cortex, serofibrinous pericarditis and esophagal erosions, besides others, were found at necropsy.
For comparison skin biopsy was taken from a patient (48 years old) with systemic scleroderma, which was taking a normal course. Cases of bronchopneumonia and a case of liver cirrhosis were also analyzed, in order to study the differences in the respective organs. Further, the composition of collagen was investigated in rheumatoid nodule and in rheumatoid synovial tissue.
Samples of organs under investigation were obtained at necropsy from 3 healthy individuals (46, 53 and 62 years old) that died during traffic accidents. The diagnoses of scleroderma and of rheumatoid arthritis were done according to the A.R.A. criteria (5).
Collagen preparations
Collagens type I and III were isolated by pepsin digestion according to Fujji & Kühn (6) and the values were calculated from the hydroxyproline content using correction factors with respect to different hydroxyproline concentration in both collagen types (7.46 for type I and 5.5 for type III).
Separation techniques
Polyacrylamide gel electrophoresis was performed by the modified method of Stark & Kühn (7), using 0-alanine buffer pH 4.3. The gels were stained with Amido Black 10 B and then evaluated at 680 nm in a Perkin Elmer UV Spectrophotometer Model 402 equipped with a gel scanning accessory.
CM cellulose chromatography (CM cellulose 52 Whatman) was by the original method ofPiez et al. (8) . The column was 1.6 X 6 cm thermostated at 40°C with a flow rate 72 ml/h. A linear gradient was prepared from two 120 ml quantities of appropriate buffers. The effluent was monitored on a UV spectrophotometer (Perkin Elmer Model 402) using an ultramicro flow-through cell at 230 nm.
Other analyses
Hydroxyproline was assayed according to Stegeman (9).
Results and Discussion
Solubility criteria have served for years äs the only indicator of differences in collagen from different sources. This included differences between normal tissues, and differences caused by pathological conditions. With the discovery of different collagen types, the question of the relative proportions of these became pertinent.
The main tissues involved in malignant systemic scleroderma were therefore investigated with respect to the content of collagen type III. Normal tissues as well as tissues affected with various diseases served as controls. The identity and purity of isolated collagen type III were proved in all samples by carboxymethyl cellulose chromatography as well as by polyaciylamide gel electrophoresis without and with dithiothreitol pretreatment ( fig. 1, 2) . Electrophoretic runs revealed the expected increase of the -band after dithiothreitol treatment. The Chromatographie and electrophoretic profiles were in all cases rather similar, and in the figures collagen type III from systemic scleroderma malignant skin is shown as an example.
The data reported here are valid of course for the pepsin solubilized fraction of insoluble collagen, as this solubilizatiori is incomplete in old tissues. According to the results of the methods used the possibility cannot be excluded that small amounts of collagen type I may be present in the fraction precipitated with 1.7 mol/1 NaCl; this would be unlikely, however, to have a pronounced effect upon the results. On the other hand basement membrane collagen (type IV) has a precipitation profile similar to that of type III (10) , and this might influence the presented data to a greater extent in liver and kidney samples. In healthy tissues the lowest amounts of collagen type HI occurred in synovial tissue and skin (about 20%), while parenchymatous organs, heart muscle and esophagus constitute about one third of pepsin solubilized collagen (tab. 1). It is to be expected that under normal conditions the amount of collagen type III will vary with age, as shown for skin by Epstein (11) and Deyl & Adam (12) . Furthermore, from the table, it is also evident that collagen type III is increased in inflammed tissues, i.e. in tissues involved with systemic sclerosis as well as with rheumatoid arthritis and bronchopneumonia.
Organ function, especially in parenchymatous organs, is affected not only by the concentration of single collagen types, but also by the total collagen content, which is also increased in diseased tissues. We suggest that this fact is very important for the function of kidney. In the case reported here, collagen exerted an indisputably critical influence on the fatal course of the disease, and the patient died from uremia. As expected from the clinical course and pathological picture, collagen metabolism was also affected in other visceral organs (liver, lung, heart muscle, esophagus).
Of particular interest are collagen changes in liver, where in cirrhosis the amount of collagen type III was lower than in healthy controls. Fleischmajer et al. (13) reported that in sclerodermous skin collagen type III is increased mainly in the lower dermis and in subcutaneous tissue.
In general, synthesis of collagen type III predominates in newly formed tissues. Gay et al. (14) showed that a single cell is capable of synthesizing both collagen types I and III. In other words it appears that there is a certain category of pathological situations in which the mechanisms determining the type of collagen to be synthesized by a certain population of fibroblasts, or the mechanisms of collagen degradation, are altered. With respect to scleroderma, the protein synthesizing mechanisms must be considered, since it has been shown by Brady (15) that in a number of organs in this disease, there is little or no collagenolytic activity.
The actual proportions between individual collagen types, as well as the total amount of collagen, are, of course, influenced by the course of the pathological process. Variations are found in the solubility of skin collagen in scleroderma, and increased as well as decreased collagen concentrations can be found in the soluble fractions (16, 17, 18) . In the active stage of scleroderma an increase of collagen biosynthesis has been definitely proved (19) , while decreased values have been described in extreme fibrosis.
It is now apparent, that in addition to being the major structural protein, stabilizing body organs by the mechanical strength of its fibers, collagen is also essential for cytodifferentiation, in which it plays a key role. Collagen metabolism and its disturbances are, from this point of view, of crucial importance. 
